Canadian medical cannabis firm Medcolcanna Organics Inc. (NEO: MCCN) announced on Thursday that it has received approval to list its common shares on the Canadian Securities Exchange.
The firm is expected to start trading its shares on the CSE big board on December 30, 2021, while it will be delisted from the Neo Exchange after the closing bell of the day before.
The company cited the opportunities that the shift to the junior stock exchange will provide, including “pursuing operations in the United States” and “[reducing] the regulatory compliance costs.”
The cannabis company, which operates in Colombia, will trade on the CSE under the same ticker symbol “MCCN”.
Medcolcanna Organics last traded at $0.035 on the NEO.
Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
